Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Nobuyuki Yamashita"'
Autor:
Eiichi, Ogawa, Makoto, Nakamuta, Toshimasa, Koyanagi, Aritsune, Ooho, Norihiro, Furusyo, Eiji, Kajiwara, Kazufumi, Dohmen, Akira, Kawano, Takeaki, Satoh, Kazuhiro, Takahashi, Koichi, Azuma, Nobuyuki, Yamashita, Naoki, Yamashita, Rie, Sugimoto, Hiromasa, Amagase, Masami, Kuniyoshi, Yasunori, Ichiki, Chie, Morita, Masaki, Kato, Shinji, Shimoda, Hideyuki, Nomura, Jun, Hayashi
Publikováno v:
Alimentary Pharmacology & Therapeutics. 56:713-722
Tenofovir alafenamide (TAF) may be preferable to other nucleos(t)ide analogues (NA) regarding outcomes against chronic hepatitis B virus (HBV) infection.To evaluate the longer term virological/biochemical effectiveness of TAF and the renal safety of
A patient with rheumatoid arthritis who developed liver cirrhosis after increased soft drinks intake
Publikováno v:
Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics. 59:244-248
A Japanese woman in her 80s with rheumatoid arthritis (RA) was admitted for weakness, edema, and ascites. She was obese (148 cm in height, 60 kg in weight) and had a high gamma-glutamyltransferase level according to her laboratory findings before tre
Autor:
Nobuyuki Yamashita, Aritsune Ooho, Shinji Shimoda, Hideyuki Nomura, Chie Morita, Jun Hayashi, Yasunori Ichiki, Eiji Kajiwara, Eiichi Ogawa, Koichi Azuma, Toshimasa Koyanagi, Takeaki Satoh, Makoto Nakamuta, Kimihiko Yanagita, Naoki Yamashita, Masami Kuniyoshi, Kazuhiro Takahashi, Akira Kawano, Kazufumi Dohmen, Norihiro Furusyo, Masaki Kato, Rie Sugimoto
Publikováno v:
Journal of Gastroenterology and Hepatology. 37:371-377
BACKGROUND AND AIM Direct-acting antivirals (DAAs) have contributed to the improvement of outcomes for all patients with chronic hepatitis C. The aim of this study was to evaluate the long-term hepatic benefits of hepatitis C virus (HCV) cure by DAAs
Autor:
Hiroki Yamamoto, Nobuyuki Yamashita, Naoyuki Ishikawa, Ryusaku Yoshiuchi, Takehisa Soma, Koichiro Kitao, Yoshihisa Honda, Taisei Hosoido
Publikováno v:
Journal of the Japan Veterinary Medical Association. 71:577-580
Autor:
Kazuhiro Takahashi, Naoki Yamashita, Eiichi Ogawa, Chie Morita, Nobuyuki Yamashita, Shinji Shimoda, Akira Kawano, Aritsune Ooho, Eiji Kajiwara, Masami Kuniyoshi, Hideyuki Nomura, Kazufumi Dohmen, Hiromasa Amagase, Koichi Azuma, Toshimasa Koyanagi, Takeaki Satoh, Makoto Nakamuta, Jun Hayashi, Rie Sugimoto, Yasunori Ichiki, Norihiro Furusyo
Background and AimsOutcome data of sequential hepatitis B virus treatment with tenofovir alafenamide (TAF) are limited. We aimed to assess the effectiveness and renal safety of TAF in chronic hepatitis B (CHB) patients who were previously treated wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::61f5f1fa54e0f2eeeb7b67939a86ffbb
https://doi.org/10.21203/rs.3.rs-268836/v1
https://doi.org/10.21203/rs.3.rs-268836/v1
Autor:
Eiichi, Ogawa, Makoto, Nakamuta, Toshimasa, Koyanagi, Aritsune, Ooho, Norihiro, Furusyo, Eiji, Kajiwara, Kazufumi, Dohmen, Akira, Kawano, Takeaki, Satoh, Kazuhiro, Takahashi, Koichi, Azuma, Nobuyuki, Yamashita, Naoki, Yamashita, Rie, Sugimoto, Hiromasa, Amagase, Masami, Kuniyoshi, Yasunori, Ichiki, Chie, Morita, Masaki, Kato, Shinji, Shimoda, Hideyuki, Nomura, Jun, Hayashi
Publikováno v:
Hepatology international. 16(2)
Outcome data of sequential hepatitis B virus treatment with tenofovir alafenamide (TAF) are limited. We aimed to assess the effectiveness and renal safety of TAF in chronic hepatitis B (CHB) patients who were previously treated with entecavir (ETV),
Autor:
Masayuki Ogawa, Daisuke Watanabe, Motonori Hirano, Hideyuki Ikematsu, Martina Kovac, Nobuyuki Yamashita
Publikováno v:
Kansenshogaku Zasshi. 92:103-114
Autor:
Yasunori Ichiki, Fumiko Hori, Shinji Simoda, Hidetaka Yamamoto, Hideyuki Nomura, Yugo Miyagi, Hironori Tanimoto, Nobuyuki Yamashita
Publikováno v:
Kanzo. 57:487-495
Autor:
Yugo Miyagi, Hideyuki Nomura, Nobuyuki Yamashita, Seiji Oohashi, Saburo Nishiura, Hidetaka Yamamoto, Yoshihiro Hayashi, Hironori Tanimoto, Hiroshi Miyagawa
Publikováno v:
Kanzo. 57:233-241
Publikováno v:
Clinical journal of gastroenterology. 11(6)
We herein report the case of a woman in her 80s with a recurrent hepatocellular carcinoma (HCC) tumor that rapidly increased in size during direct-acting antiviral (DAA) treatment. She suffered from HCC at her initial visit to our department and unde